Prætorius, Thim http://orcid.org/0000-0002-0192-4972
Baymler Lundberg, Anne Sofie
Søndergaard, Esben
Tang Knudsen, Søren
Sandbæk, Annelli
Funding for this research was provided by:
Region Midtjylland (1-30-72-404-21)
Article History
Received: 7 March 2022
Accepted: 25 November 2022
First Online: 28 December 2022
Declarations
:
: The Research Ethics Committees for Central Denmark Region (no. 1–10-72–274-21) concludes that the study could be conducted without an approval from the committee because “According to the Consolidation Act on Research Ethics Review of Health Research Projects, Consolidation Act number 1083 of 15 September 2017, section 14(2) notification of questionnaire surveys or medical database research projects to the research ethics committee system is only required if the project involves human biological material” (ExternalRef removed).The Committee of Multipractice Studies in General Practice (journal no. 15–2021) evaluated the study and concludes that it is relevant and thoroughly prepared and leaves the decision to participate in the study to the general practitioners.The study is reported to The Danish Data Protection Agency (journal no. 1–16-02–398-21). In accordance with the Danish Data Protection Agency, we report that the expected time for completion of the project and deletion, anonymization, or transfer to the National Archives is 4 October 2026.GPs must consent to participate in the intervention and collect the data needed to measure the patient and general practice outcomes. A hospital secretary will collect the signed informed consent to participate in print before randomization. Endocrinologists participating from Steno Diabetes Center Aarhus must provide written informed consent to participate in the intervention. Data will not be collected for the purposes of ancillary studies that are separate from the main trial.
: Written consent to participate and to use data from the study for publication will be collected.
: STK declares receiving honoraria for lectures from Boehringer Ingelheim, Sanofi, Mundipharma, Novo Nordisk, MSD, and AstraZeneca and research grants from Novo Nordisk and AstraZeneca. The other authors declare no conflicts of interest.